Kolexia
Guerin-Meyer Veronique Gastro-entérologie
Guerin-Meyer Veronique
Gastro-entérologie
Ico - Site Paul Papin
Angers, France
65 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Tumeurs du côlon Adénocarcinome Déficit en dihydropyrimidine déshydrogénase Tumeurs du foie Tumeurs du rectum Tumeurs du pancréas Tumeurs de l'oesophage

Collaborateurs

Voir plus
Capitain Olivier
Capitain Olivier
Ico - Site Paul Papin, Angers, France
Faroux Roger
Faroux Roger
Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France
Metges Jean-Philippe
Metges Jean-Philippe
Hôpital Morvan, Brest, France
Cojocarasu Oana
Cojocarasu Oana
Centre Hospitalier du Mans, Le Mans, France

Industries

Voir plus
Servier
9 collaboration(s)
Dernière en 2023
Amgen
3 collaboration(s)
Dernière en 2023
Pierre Fabre
2 collaboration(s)
Dernière en 2023
Merck-Serono
1 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
OSCAR: Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study.
Cancers   06 avril 2023
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   14 septembre 2022
Aflibercept-LV5FU2 as first-line treatment of non-resectable metastatic colorectal cancers: Results of the FOLFA randomized phase II trial.
2022 ASCO Annual Meeting I   02 juin 2022
SULTAN: A Randomized Phase II Study Comparing Treatment Intensification With CIAH Plus Systemic Chemotherapy to Systemic Chemotherapy Alone in Patients With Liver-only Colorectal Metastases Considered Still Non Resectable After at Least Two Months of Systemic Induction Chemotherapy
Essai Clinique (Unicancer)   03 janvier 2022
Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial.
JAMA network open   01 octobre 2020
444P PRODIGE 25 (FFCD 11-01)-FOLFA: A randomized phase II trial evaluating aflibercept associated with LV5FU2 regimen as first-line treatment of non-resectable metastatic colorectal cancers
Abstract Book of the ESMO Virtual Congress2020 19 – 21 September / 16 – 18 October 2020   01 septembre 2020
Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer: Multicenter Phase III Randomized Study of FOLFIRI Plus Bevacizumab Following or Not by a Maintenance Therapy With Bevacizumab in Patients With Non-Pretreated Metastatic Colorectal Cancer
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   27 mars 2020
Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial.
British journal of cancer   04 février 2020
Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol.
BMC cancer   30 janvier 2020